Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
101M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
29.5M
-
Shares change
-
+1.81M
-
Total reported value, excl. options
-
$727M
-
Value change
-
+$39.4M
-
Number of buys
-
52
-
Number of sells
-
-21
-
Price
-
$24.62
Significant Holders of Beam Therapeutics Inc. - Common Stock (BEAM) as of Q3 2020
92 filings reported holding BEAM - Beam Therapeutics Inc. - Common Stock as of Q3 2020.
Beam Therapeutics Inc. - Common Stock (BEAM) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.5M shares
of 101M outstanding shares and own 29.35% of the company stock.
Largest 10 shareholders include FMR LLC (7.33M shares), Temasek Holdings (Private) Ltd (3.35M shares), Redmile Group, LLC (3.33M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (2.97M shares), VANGUARD GROUP INC (2.25M shares), BlackRock Inc. (2.23M shares), SC CHINA HOLDING Ltd (1.13M shares), FIL Ltd (816K shares), Cormorant Asset Management, LP (796K shares), and Alphabet Inc. (664K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.